Geode Capital Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $278M | Buy |
11,302,057
+109,653
| +1% | +$2.54M | 0.01% | 667 |
|
|
2026
Q1 | $268M | Buy |
11,192,404
+1,766,871
| +19% | +$43.2M | 0.02% | 621 |
|
|
2025
Q4 | $213M | Buy |
9,425,533
+640,098
| +7% | +$13.9M | 0.01% | 697 |
|
|
2025
Q3 | $177M | Buy |
8,785,435
+716,638
| +9% | +$12M | 0.01% | 754 |
|
|
2025
Q2 | $115M | Sell |
8,068,797
-282,269
| -3% | -$3.3M | 0.01% | 938 |
|
|
2025
Q1 | $87.7M | Buy |
8,351,066
+170,226
| +2% | +$1.93M | 0.01% | 1051 |
|
|
2024
Q4 | $99.1M | Buy |
8,180,840
+312,165
| +4% | +$4.08M | 0.01% | 1011 |
|
|
2024
Q3 | $116M | Buy |
7,868,675
+65,303
| +0.8% | +$910K | 0.01% | 893 |
|
|
2024
Q2 | $113M | Buy |
7,803,372
+169,269
| +2% | +$2.7M | 0.01% | 858 |
|
|
2024
Q1 | $124M | Buy |
7,634,103
+287,561
| +4% | +$4.5M | 0.01% | 793 |
|
|
2023
Q4 | $109M | Buy |
7,346,542
+197,314
| +3% | +$2.23M | 0.01% | 814 |
|
|
2023
Q3 | $80.4M | Buy |
7,149,228
+471,138
| +7% | +$5.47M | 0.01% | 904 |
|
|
2023
Q2 | $67.2M | Buy |
6,678,090
+607,315
| +10% | +$5.64M | 0.01% | 1040 |
|
|
2023
Q1 | $57M | Buy |
6,070,775
+142,802
| +2% | +$1.68M | 0.01% | 1098 |
|
|
2022
Q4 | $72.4M | Buy |
5,927,973
+1,226
| +0% | +$15.3K | 0.01% | 897 |
|
|
2022
Q3 | $73.5M | Buy |
5,926,747
+44,297
| +0.8% | +$774K | 0.01% | 837 |
|
|
2022
Q2 | $115M | Buy |
5,882,450
+63,350
| +1% | +$1.5M | 0.02% | 626 |
|
|
2022
Q1 | $152M | Buy |
5,819,100
+214,192
| +4% | +$5.7M | 0.02% | 618 |
|
|
2021
Q4 | $159M | Buy |
5,604,908
+191,387
| +4% | +$5.95M | 0.02% | 613 |
|
|
2021
Q3 | $172M | Sell |
5,413,521
-7,362
| -0.1% | -$247K | 0.02% | 569 |
|
|
2021
Q2 | $188M | Buy |
5,420,883
+204,257
| +4% | +$6.74M | 0.03% | 553 |
|
|
2021
Q1 | $153M | Buy |
5,216,626
+305,739
| +6% | +$9.4M | 0.02% | 589 |
|
|
2020
Q4 | $150M | Buy |
4,910,887
+1,429,649
| +41% | +$43.6M | 0.03% | 556 |
|
|
2020
Q3 | $97.1M | Sell |
3,481,238
-680,937
| -16% | -$17.3M | 0.02% | 616 |
|
|
2020
Q2 | $89.2M | Buy |
4,162,175
+50,684
| +1% | +$1.12M | 0.02% | 606 |
|
|
2020
Q1 | $92M | Buy |
4,111,491
+319,134
| +8% | +$8.74M | 0.02% | 527 |
|
|
2019
Q4 | $112M | Buy |
3,792,357
+152,177
| +4% | +$4.14M | 0.02% | 570 |
|
|
2019
Q3 | $96.7M | Buy |
3,640,180
+106,624
| +3% | +$3.2M | 0.02% | 583 |
|
|
2019
Q2 | $119M | Buy |
3,533,556
+293,234
| +9% | +$9.52M | 0.03% | 515 |
|
|
2019
Q1 | $104M | Buy |
3,240,322
+2,650,638
| +450% | +$81.6M | 0.03% | 538 |
|
|
2018
Q4 | $18.6M | Buy |
+589,684
| New | +$19.3M | 0.01% | 1332 |
|
Other funds holding ELAN
BCIM
Geode Capital Management's ELAN Position: Q2 2026 in Review
Geode Capital Management increased its Elanco Animal Health (ELAN) stake by 0.98% in Q2 2026, buying an estimated $2.54M and bringing the position to 11,302,057 shares worth $278M. The position accounts for 0.01% of the portfolio, ranked #667.
Geode Capital Management first reported a position in ELAN in Q4 2018 and has held it in 31 quarters since. 491 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- Geode Capital Management held 11,302,057 shares of Elanco Animal Health worth $278M as of Q2 2026.
- Geode Capital Management bought 109,653 Elanco Animal Health shares in Q2 2026, an estimated $2.54M.
- Elanco Animal Health made up 0.01% of Geode Capital Management's portfolio in Q2 2026, its #667 holding.
- Geode Capital Management first reported a position in Elanco Animal Health in Q4 2018 and has held it in 31 quarters since.
- 491 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.